EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial

Jiandong Zhang, Kai Zhao, Weihang Zhou, Guixing Jiang, Ying Ding, Yizhuo Zhang iD, Xinyu Dong, Defei Hong, Xiaolong Liu

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s568812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiandong Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Deoxycytidine, Liver Neoplasms, Pancreatic Neoplasms, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidineLiver NeoplasmsPancreatic NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsAlbumin-Bound PaclitaxelHumansPilot ProjectsGemcitabineMaleFemaleMiddle AgedProspective StudiesAgedAdult

Stichwörter der Autor:innen

camrelizumabchemotherapyliver metastasespancreatic ductal adenocarcinoma

Substanzen

GemcitabineDeoxycytidineAntibodies, Monoclonal, HumanizedcamrelizumabAlbumin-Bound Paclitaxel

Autor:innen und Institutionen

  • Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Department of Intensive Care Unit, Sir Run Run Shaw Hospital Qiantang Campus, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

ORCID-Profile: Yizhuo Zhang

Zitieren

APA

Zhang, J., Zhao, K., Zhou, W., Jiang, G., Ding, Y., Zhang, Y., Dong, X., Hong, D., & Liu, X. (2026). Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s568812

Vancouver

Zhang J, Zhao K, Zhou W, Jiang G, Ding Y, Zhang Y, et al. Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s568812

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiandong and Zhao, Kai and Zhou, Weihang and Jiang, Guixing and Ding, Ying and Zhang, Yizhuo and Dong, Xinyu and Hong, Defei and Liu, Xiaolong},
  title = {Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s568812}
}
Kostenlos starten →